Research output

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

  • Vishwanathan, K.
  • Dickinson, P. A.
  • So, K.
  • Thomas, K.
  • Chen, Y.
  • Carpeno, J.
  • Dingemans, A.C.

  • Kim, H. R.
  • Kim, J.
  • Krebs, M. G.
  • Yang, J. C.
  • Bui, B.
  • Weilert, D.
  • Harvey, R. D.

Associated organisations

    Research areas

  • clinical pharmacology, drug metabolism, drug analysis, lung cancer, drug information, oncology, pharmacokinetics, biomarkers, drug interactions, CELL LUNG-CANCER, SYSTEMIC ANTIMYCOTICS KETOCONAZOLE, GROWTH-FACTOR RECEPTOR, DRUG-DRUG INTERACTION, PHASE-III, OPEN-LABEL, ACQUIRED-RESISTANCE, 1ST-LINE TREATMENT, T790M MUTATION, EGFR MUTATIONS
View graph of relations


Original languageEnglish
Pages (from-to)1156-1169
Number of pages14
JournalBritish Journal of Clinical Pharmacology
Issue number6
Publication statusPublished - 1 Jun 2018